Quantcast

Latest Molecular imaging Stories

2011-07-18 07:30:00

PHOENIX, July 18, 2011 /PRNewswire/ -- Today in Phoenix, Cardinal Health opened The Center for the Advancement of Molecular Imaging (The Center) - a new, first-of-its-kind collaboration laboratory that will expedite the development of nuclear imaging agents that treat complex diseases like cancer, heart disease and neurological disorders. Cardinal Health's industry-leading scientists, engineers and manufacturing experts will leverage state-of-the-art technology and infrastructure at the...

2011-07-07 08:35:00

CULVER CITY, Calif., July 7, 2011 /PRNewswire/ -- Sofie Biosciences, developer of molecular imaging systems and probes, has been awarded a 2011 Phase I Small Business Innovation Research grant from the Department of Energy. Of the 2,163 applications received in response to their funding notice, only 197 were selected to receive Phase I grants. (Logo: http://photos.prnewswire.com/prnh/20101208/LA13841LOGO) Positron Emission Tomography (PET) is a molecular imaging modality that utilizes...

2011-06-29 07:00:00

CAGE Chemicals, University of Turin and Aspect Imaging to Develop Applications and Products for Molecular Imaging on Aspect's M2(TM) Compact MRI System for Preclinical Imaging TORONTO, Canada, SHOHAM, Israel, and TURIN, Italy, June 29, 2011 /PRNewswire/ - Aspect Imaging today announced its agreement with CAGE Chemicals to develop and manufacture Aspect's PhenoQuant(TM) line of contrast agents for preclinical research. A third contributor in the partnership, University of Turin's...

2011-06-14 08:00:00

AUGUSTA, Ga., June 14, 2011 /PRNewswire/ -- Cardinal Health today opened its first cyclotron facility in the state of Georgia, further expanding its nationwide capability to manufacture molecular imaging biomarkers that aid in the early diagnosis, monitoring and treatment of cancer, neurological disorders and heart disease. Cyclotrons are critical to the manufacturing process for Positron Emission Tomography (PET) molecular imaging agents, one of the fastest-growing areas of nuclear...

2011-06-06 11:53:00

OXFORD, United Kingdom, June 6, 2011 /PRNewswire/ -- Oxford BioMedicaplc ("Oxford BioMedica" or "the Company") (LSE: OXB), a leading gene therapy company, today announces that it has signed a research collaboration agreement with ImaginAb, Inc. ("ImaginAb"), a biotechnology company specialising in the development of engineered antibody fragments for diagnostic imaging and novel therapeutic applications, to engineer an in vivo diagnostic imaging agent using an antibody targeting the...

2011-06-03 08:00:00

SAN ANTONIO, June 3, 2011 /PRNewswire/ -- At the 2011 SNM Annual Meeting in San Antonio, Siemens Healthcare (booth #6033) will address the increasing demand for molecular imaging procedures and Siemens' efforts to expand molecular imaging's availability in three directions: patient access, clinical utilization, and new clinical applications. Through this benchmark-redefining growth of molecular imaging, Siemens (NYSE: SI) is "Expanding Your Return on Innovation." (Logo:...

2011-06-02 07:00:00

NEWPORT NEWS, Va., June 2, 2011 /PRNewswire/ -- Dilon Diagnostics will introduce the latest advancement in molecular breast imaging (MBI) this week at the Society of Nuclear Medicine (SNM) Meeting in San Antonio, Texas, with the premiere of its FDA-cleared Dilon 6800® Acella Gamma Camera system. To complement the already widely successful Dilon 6800® standard field-of-view imaging system, the new camera will feature a much larger MBI detector which will...

2011-05-03 10:00:00

SAN DIEGO, May 3, 2011 /PRNewswire/ -- Researchers from the University of Cincinnati presented results from a prospective study at the American Roentgen Ray Society 2011 Annual Meeting today, demonstrating how PEM-guided biopsy may expedite pre-operative work-up and reduce radiation exposure for breast cancer patients. PEM scanners are high-resolution breast PET systems that can show the location as well as the metabolic phase of a lesion. This information is critical in determining...

2011-04-18 07:00:00

LOS ANGELES, April 18, 2011 /PRNewswire/ -- ImaginAb, Inc. and the University of California, Los Angeles (UCLA) have concluded a technology licensing agreement relating to novel fluorine chemistry for the rapid and robust labeling of proteins, peptides and biomolecules for diagnostic imaging with Positron Emission Tomography (PET). "We are pleased that ImaginAb has expanded its technology portfolio and recognized the cutting-edge work being developed by the Crump Institute," said Dr....

2011-04-11 13:37:00

LOS ANGELES and KYOTO, Japan, April 11, 2011 /PRNewswire/ -- ImaginAb, Inc. and Dainippon Seiki Co., Ltd. have concluded a technology agreement around the development of automated chemistry systems for fluorination of proteins and peptides for diagnostic imaging with positron emission tomography (PET). "Over the past 18 months, our academic and pharma client base has dramatically increased and we have been developing and in-licensing novel fluorine chemistries to streamline labeling of...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'